Growth/differentiation factor-15 (GDF-15), a novel member of the TGF-β superfamily, promotes survival of lesioned mesencephalic dopaminergic neurons in vitro and in vivo and is induced in neurons following cortical lesioning

Journal of Neural Transmission, Supplement

Volumn , Issue 65, 2003, Pages 197-203

  Strelau, J ^a   Schober, A ^a   Sullivan, A ^b   Schilling, L ^a   Unsicker, E ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH DIFFERENTIATION FACTOR 5; OXIDOPAMINE; TRANSFORMING GROWTH FACTOR BETA; ADRENERGIC RECEPTOR STIMULATING AGENT; CYTOKINE; DOPAMINE; NEUROPROTECTIVE AGENT; PLAB PROTEIN;

BIOSYNTHESIS; BRAIN CORTEX LESION; CELL CULTURE; CELL DEATH; CELL DIFFERENTIATION; CELL POPULATION; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CHOROID PLEXUS; CLONING; CONFERENCE PAPER; DOPAMINERGIC NERVE CELL; EXPERIMENTAL MODEL; GLIA CELL; MACROPHAGE; MESENCEPHALON; MICROGLIA; NEUROPROTECTION; NEUROTROPISM; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAPHE NUCLEUS; ANIMAL; BRAIN CORTEX; CHEMISTRY; DRUG EFFECT; GENETICS; GLIA; METABOLISM; NERVE CELL; PATHOLOGY; REVIEW; SUBSTANTIA NIGRA; TISSUE DISTRIBUTION;

ADRENERGIC AGENTS; ANIMALS; CELL DEATH; CELL DIFFERENTIATION; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; CEREBRAL CORTEX; CYTOKINES; DOPAMINE; MESENCEPHALON; NEUROGLIA; NEURONS; NEUROPROTECTIVE AGENTS; OXIDOPAMINE; RAPHE NUCLEI; SUBSTANTIA NIGRA; TISSUE DISTRIBUTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 0141940623     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-0643-3_12     Document Type: Conference Paper

References (13)

1. Bootcov MR, Bauskin AR, Valenzuela SM, Moore AG, Bansal M, He XY, Zhang HP, Donnellan M, Mahler S, Pryor K, Walsh BJ, Nicholson RC, Fairlie WD, Por SB, Robbins JM, Breit SN (1997) MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta super-family. Proc Natl Acad Sci USA 94: 11514-11519
2. Böttner M, Laaff M, Schechinger B, Rappold G, Unsicker K, Suter-Crazzolara C (1999) Characterization of the rat, mouse, and human genes of growth/differentiation factor-15/macrophage inhibiting cytokine-1 (GDF-15/MIC-1). Gene 237: 105-111
3. Böttner M, Suter-Crazzolara C, Schober A, Unsicker K (1999) Expression of a novel member of the TGF-beta superfamily, growth/ differentiation factor-15/macrophage-inhibiting cytokine-1 (GDF-15/MIC-1) in adult rat tissues. Cell Tissue Res 297: 103-110
4. Dunnett SB, Bjorklund A (1999) Prospects for new restorative and neuroprotective treatments in Parkinson's disease. Nature 399: 32-39
5. Gerlach M, Riederer P (1996) Pathogenesis and neuroprotective therapy trial in chronic degenerative diseases. Status of antioxidants. Med Klin 91: 163-170
6. Krieglstein K, Richter S, Farkas L, Schuster N, Dünker N, Oppenheim RW, Unsicker K (2000) Reduction of endogenous transforming growth factors beta prevents ontogenetic neuron death. Nat Neurosci 3: 1085-1090
7. Krieglstein K, Suter-Crazzolara C, Hotten G, Pohl J, Unsicker K (1995) Trophic and protective effects of growth/differentiation factor 5, a member of the transforming growth factor-beta superfamily, on midbrain dopaminergic neurons. J Neurosci Res 42: 724-732
8. Olanow CW, Tatton WG (1999) Etiology and pathogenesis of Parkinson's disease. Annu Rev Neurosci 22: 123-144
9. Otto D, Unsicker K (1990) Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice. J Neurosci 10: 1912-1921
10. Schober A, Böttner M, Strelau J, Kinscherf R, Bonaterra GA, Barth M, Schilling L, Fairlie WD, Breit SN, Unsicker K (2001) Expression of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in the perinatal, adult, and injured rat brain. J Comp Neurol 439: 32-45
11. Strelau J, Sullivan A, Böttner M, Lingor P, Falkenstein E, Suter-Crazzolara C, Galter D, Jaszai J, Krieglstein K, Unsicker K (2000) Growth/differentiation factor-15/macrophage inhibitory cytokine-1 is a novel trophic factor for midbrain dopaminergic neurons in vivo. J Neurosci 20: 8597-8603
12. Sullivan AM, Opacka-Juffry J, Blunt SB (1998) Long-term protection of the rat nigrostriatal dopaminergic system by glial cell line-derived neurotrophic factor against 6-hydroxydopamine in vivo. Eur J Neurosci 10: 57-63
13. Sullivan AM, Opacka-Juffry J, Hotten G, Pohl J, Blunt SB (1997) Growth/differentiation factor 5 protects nigrostriatal dopaminergic neurones in a rat model of Parkinson's disease. Neurosci Lett 233: 73-76